The prevalence of obesity in the United States has been steadily increasing over the past three decades, with a significant rise in the number of adults and adolescents living with overweight and obesity. According to a recent analysis published in The Lancet by the Global Burden of Disease Study Collaborator Network, the number of people living with overweight and obesity exceeded 208 million in 2021, and this trend is expected to continue in the coming years without significant intervention.
The analysis revealed alarming statistics, with certain states in the U.S. already experiencing high levels of overweight and obesity. For instance, over half of older adolescent males in Texas and nearly two-thirds of older adolescent females in Mississippi were living with overweight or obesity in 2021. Similarly, around 80% of men in North Dakota and women in Mississippi were estimated to have overweight or obesity in the same year.
The study also projected devastating trends for the future, with the total number of children, adolescents, and adults with overweight and obesity expected to reach 43.1 million and 213 million, respectively, by 2050. The implications of this epidemic are far-reaching, as it can lead to serious health conditions such as diabetes, heart disease, stroke, cancer, mental health disorders, and premature death.
Lead author Professor Emmanuela Gakidou emphasized the urgent need for population-wide action to reverse these trends and address the disparities in geographical and sex prevalence of overweight and obesity. The analysis provided detailed forecasts at the state level, highlighting the need for comprehensive strategies to combat this public health crisis.
The study also shed light on the unprecedented epidemic of childhood and adolescent obesity, with older adolescent obesity prevalence more than doubling between 1990 and 2021. The prevalence of obesity is projected to increase at a faster rate than overweight, affecting at least one in five children and one in three adolescents by 2050.
To address this crisis, the authors emphasized the importance of population-level prevention and a cross-government strategy. While anti-obesity medications may have a role in obesity management, they are not a standalone solution. Prevention efforts, backed by high-level political commitment and comprehensive policies, are crucial to tackling the obesity epidemic effectively.
In conclusion, the rising rates of overweight and obesity in the U.S. require immediate and concerted action at all levels of society. By implementing multifaceted strategies that prioritize prevention and address structural drivers of obesity, we can work towards a healthier future for current and upcoming generations.
